Litigation Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
✉ Email this page to a colleague
POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-10-22 |
Court | District Court, D. New Jersey | Date Terminated | 2019-09-10 |
Cause | 15:78m(a) Securities Exchange Act | Assigned To | Michael Andre Shipp |
Jury Demand | Both | Referred To | Lois H. Goodman |
Patents | 7,326,711 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
The biologic drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-04-22 | 539 | Exhibit Seeger Decl Ex. H - Class Cert Brief | .86 $93.88 $93.91 7,326,711 1.74% 12/9/2015 $94.40 …Allergan PLC was challenging the patent to a key drug, and then saw Moody's put it | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |